This page contains a Flash digital edition of a book.
INDUSTRY INSIDER | LIGHT-BASED DEVICES | wavelength of 640 nm, which is


plastered directly to the skin lesion. The patient will keep it on for 3 hours with the light off and 3 hours with the light on. The manufacturer calls it 'therapy in motion'. Some northern European countries


are also experimenting with daylight-mediated


PDT.


Daylight-mediated PDT reduces the time a patient spends in a doctorÕs office and may serve as an alternative to conventional PDT. In a randomised study carried out in 2011, the Department of Dermatology at the University of Copenhagen showed that daylight PDT can be an effective and convenient treatment as there is no need for a medical light source for patients with multiple thin actinic keratoses. The procedures were easily performed and 2 hours of daylight exposure resulted in uniformly high response rates when conducted in the period from June to October in Nordic countries. All 20 patients enrolled in the study were given sunscreen. Sun-activated medical and non-medical therapies could become a very dynamic segment in the next 5 years. The medical PDT market is


growing, and a new actor is entering to challenge the two leading brands, Levulan from Dusa and Metvix from Galderma. The German pharmaceutical company Biofrontera is completing phase 3 clinical trials for its new drug BF-200 ALA, with an ALA concentration of 10% (lower than the leading actors, but with similar results according to companyÕs tests).


PDT is also being more researched to


treat skin ageing (fine lines and wrinkles, hyperpigmentation, rosacea) as PDTÕs most common side-effect is a local rejuvenation of the skin tissue that has been treated. Some studies have shown that dermal thickness increases, along with improvements in collagen and elastic tissue.


Blue light has been used by


dermatologists for many years to treat acne. A major


attraction is that it is a drug-free treatment


without the side-effects of conventional treatments.


LLLT Low-level laser therapy (LLLT) ® also referred to as photobiomodulation (PBM) ® is gaining momentum. LLLT is the application of light (usually a low-power laser or LED) to promote tissue repair, reduce inflammation or induce analgesia. The effects of LLLT can be explained by light absorption in the mitochondria, where it interacts with the mitochondrial protein cytochrome oxidase. Every cell in the body has lots of mitochondria, the job of which is to make cellular energy (ATP). Treatments with


LLLT


technologies ® especially the visible light and near infrared spectrums ® are growing in both the aesthetic and medical worlds. The majority of clinical evidence for LLLT is for treating musculoskeletal pain: neck pain, tendinopathies, osteoarthritis, and oral mucositis (post-radio/ chemotherapy). However, LLLT is also becoming a treatment for serious medical conditions. Harvard medical school is


working on traumatic brain injury, spinal- cord injuries, and the side-effects of chemotherapy, and MIT is working on US army amputees. The therapy is also


beginning to be used to treat strokes, depression, and pressure ulcers. Blue light has been used by


dermatologists for many years to treat acne. A major attraction is that it is a drug-free treatment without


the


side-effects of conventional treatments (i.e. antibiotics, topical creams and contraceptive pills). Consensus has held that visible blue light at a wavelength of 420 nm does not cause damage to the skin, but is effective in killing the bacteria that causes acne. Acording to the some recent research,


however, blue light is only really effective at killing bacteria in the lab, and its efficacy on the skin tissue in vivo is more questionable. The problem with blue light is said to be that it does not penetrate the skin deeply enough. Alternatives are therefore being sought. According to James Caroll of THOR Photomedicine Ltd, red and near-infrared light is showing good results in acne treatment. Indeed, there is a new generation of


at-home phototherapy devices for acne, such as LMS (Love My Skin) Spotlight 24, launched at Boots Pharmacies last autumn, that use only red light and infrared light. The primary effect of the red light therapy in LMS Spotlights is to penetrate the skin cells to force out nitric oxide and stimulate antioxidants. This has been shown to reduce cellular stress and increase cellular energy (ATP), leading to improved healing and repair of the skin in a wide range of medical conditions, including spots and acne. The device is easy to use and has short treatment times ® only 1 minute, three times per day, for optimal performance (LMS Spotlights have a built-in timer). The red and infrared wavelengths are


continuing to be popular to rejuvenate both the skin and the whole body. The Omnilux new-U is one of the few approved by the US Food and Drug Administration (FDA). Clinical trials show that after eight 20-minute treatments over 4 weeks, three quarters of patients showed a significant improvement to fine lines and wrinkles. However, LLLT therapies are highly


14 ❚


controversial, with many experts challenging their claimed results. According to Dr Janis T. Eells, a specialist in LLLT and graduate program director for biomedical sciences at the College of Health Sciences at the University of Wisconsin-Milwaukee, for LLLT to be effective, the various irradiation


January/February 2013 | prime-journal.com


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92